1Division of Hospital Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA.
2Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.
3Department of Critical Care Medicine, Taichung Veteran General Hospital, Taichung, Taiwan.
4Section of Pulmonary and Critical Care Medicine, Department of Medicine, Louisiana State University School of Medicine New Orleans, LA.
5Division of Pulmonary and Critical Care, University of California, San Francisco, San Francisco, CA.
6Departments Medicine and Anesthesia and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA.
*See also p. 246.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Dr. Kangelaris was supported by the Society of Hospital Medicine Young Researchers Award, the National Institutes of Health (NIH) National Center for Advancing Translational Sciences through UCSF-CTSI KL2 TR000143, and National Heart, Lung, and Blood Institute (NHLBI) 1K23HL116800-01. Dr. Ware has served on a medical advisory board for Glaxo Smith Kline and as a consultant for Abbot. She was supported by NHLBI HL112656, and HL103836 and received support for article research from the NIH. Her institution received grant support from the NIH and the American Heart Association. Dr. Janz was supported by NIH T32 HL087738. Dr. Zhuo received support for article research from the NIH. Dr. Matthay has served on medical advisory boards for Cerus (ARDS consult - money paid to Dr. Matthay), GlaxoSmithKline (consultant for ARDS and grant for studies of sepsis, grant to UCSF his institution), and Roche Genentec (Chair of DSMB for Asthma trials). He was supported by NHLBI R37 HL51856. He received funding from Quark Pharmaceuticals, received support for article research from the NIH. Dr. Calfee has served on medical advisory boards for Cerus and GlaxoSmithKline. She was supported by HL110969. She received support for travel from Boehringer Ingelheim (travel for meeting related to potential research grant) and for article research from the NIH. Drs. Calfee and Matthay have also received grant support from GlaxoSmithKline. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]
